Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of ezetimibe 10 mg tablets in healthy Thai volunteers
TCTR20170719004Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of ezetimibe, sponsored by Bio-innova. Primary endpoints: Cmax and AUC0-72. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
ezetimibe
Beyond the preview
Go deeper on TCTR20170719004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170719004.